Onconetix, Inc. Cash
Onconetix, Inc. (ONCO) had Cash of $5.94 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2026-08-13
- 2026-06-30: Cash $5.94M.
- 2026-03-31: Cash $3.72M.
- 2025-12-31: Cash $5.22M.
- 2025-09-30: Cash $836.56K.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2026-06-30 | $5.94M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $3.72M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $5.22M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $836.56K 10-Q · filed 2025-11-13 | |
| 2025-08-13 | $200.00K 10-Q · filed 2025-08-14 | |
| 2025-06-30 | $283.51K 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $1.58M 10-Q · filed 2025-06-12 | |
| 2024-12-31 | $646.50K 10-K · filed 2026-03-13 | $600.00K 10-K · filed 2025-06-02 |
| 2024-09-30 | $300.00K 10-Q · filed 2024-12-10 | |
| 2024-03-31 | $4.46M 10-Q · filed 2024-05-20 | |
| 2023-12-31 | $4.55M 10-Q · filed 2024-05-20 | |
| 2023-09-30 | $7.65M 10-Q · filed 2023-11-17 | |
| 2023-06-30 | $9.22M 10-Q · filed 2023-10-20 | |
| 2023-03-31 | $20.26M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $25.75M 10-K · filed 2024-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |